MedTrace Logo

A Study to Evaluate Efficacy of IP on Alertness and Mental Fatigue

NCT02816827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2016-09-09

No results posted yet for this study

Summary

The current study is design to asses the effect of E-AG-01/ E-AG-02/ E-AG-03 on mental alertness as compared to placebo.

Conditions

  • Mental Fatigue

Interventions

DIETARY_SUPPLEMENT

AG-01

Product to increase mental alertness

DIETARY_SUPPLEMENT

AG-05

Product to increase mental alertness

DIETARY_SUPPLEMENT

AG-06

Product to increase mental alertness

DIETARY_SUPPLEMENT

AG-07

Product to increase mental alertness

Sponsors & Collaborators

  • Enovate Biolife Pvt Ltd

    collaborator INDUSTRY

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Shalini Srivastav, M D · Enovate Biolife Pvt Ltd

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816827 on ClinicalTrials.gov